Working with TipRanks
Follow Us
Stocks
ETFs
Options
Crypto
Research Tools
Calendars
Calculators
Education
About Us
Working with TipRanks
Follow Us
ACADIA Pharmaceuticals (ACAD)
NASDAQ:ACAD
ACADIA Pharmaceuticals (ACAD) Stock Price & Analysis
2,004 Followers
ACAD Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$14.45 - $33.99
Previous Close$22.29
Volume533.36K
Average Volume (3M)1.58M
Market Cap
$3.63B
Enterprise Value$3.43B
Total Cash (Recent Filing)$366.69M
Total Debt (Recent Filing)$48.10M
Price to Earnings (P/E)-24.4
Beta0.62
Next Earnings
Feb 26, 2024EPS Estimate
$0.31Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.91
Shares Outstanding164,180,377
10 Day Avg. Volume1,021,946
30 Day Avg. Volume1,583,117
Standard Deviation0.14
R-Squared0.05
Alpha0.00766
Financial Highlights & Ratios
Price to Book (P/B)12.70
Price to Sales (P/S)26.81
Price to Cash Flow (P/CF)-15.90
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/Revenue5.43
Enterprise Value/Gross Profit6.77
Enterprise Value/Ebitda-24.75
Forecast
1Y Price Target
$33.83Price Target Upside56.69% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering12
ACADIA Pharmaceuticals News
ACAD FAQ
What was ACADIA Pharmaceuticals’s price range in the past 12 months?
ACADIA Pharmaceuticals lowest stock price was $14.45 and its highest was $33.99 in the past 12 months.
What is ACADIA Pharmaceuticals’s market cap?
Currently, no data Available
When is ACADIA Pharmaceuticals’s upcoming earnings report date?
ACADIA Pharmaceuticals’s upcoming earnings report date is Feb 26, 2024 which is in 82 days.
How were ACADIA Pharmaceuticals’s earnings last quarter?
ACADIA Pharmaceuticals released its earnings results on Nov 02, 2023. The company reported -$0.4 earnings per share for the quarter, beating the consensus estimate of -$0.448 by $0.048.
Is ACADIA Pharmaceuticals overvalued?
According to Wall Street analysts ACADIA Pharmaceuticals’s price is currently Undervalued.
Does ACADIA Pharmaceuticals pay dividends?
ACADIA Pharmaceuticals does not currently pay dividends.
What is ACADIA Pharmaceuticals’s EPS estimate?
ACADIA Pharmaceuticals’s EPS estimate is $0.31.
How many shares outstanding does ACADIA Pharmaceuticals have?
ACADIA Pharmaceuticals has 164,180,370 shares outstanding.
What happened to ACADIA Pharmaceuticals’s price movement after its last earnings report?
ACADIA Pharmaceuticals reported an EPS of -$0.4 in its last earnings report, beating expectations of -$0.448. Following the earnings report the stock price went up 4.698%.
Which hedge fund is a major shareholder of ACADIA Pharmaceuticals?
Among the largest hedge funds holding ACADIA Pharmaceuticals’s share is Baker Bros Advisors LP. It holds ACADIA Pharmaceuticals’s shares valued at 893M.
---
ACADIA Pharmaceuticals Stock Smart Score
Underperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$33.83 (56.69% Upside)
$33.83 (56.69% Upside)
Blogger Sentiment
Bullish
ACAD Sentiment 100%
Sector Average 71%
Sector Average 71%
Hedge Fund Trend
Decreased
By 924.8K Shares
Last Quarter.
Last Quarter.
Insider Transactions
Sold Shares
Worth $1.5M over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Positive
Last 7 Days ▼ 0.2%
Last 30 Days ▲ 3.2%
Last 30 Days ▲ 3.2%
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Negative
20 days / 200 days
Momentum
46.25%
12-Months-Change
Fundamentals
Return on Equity
-37.78%
Trailing 12-Months
Asset Growth
4.99%
Trailing 12-Months
Learn more about TipRanks Smart Score
Company Description
ACADIA Pharmaceuticals
ACADIA Pharmaceuticals, Inc. operates as a biopharmaceutical company focused on the development and commercialization of medicines to address unmet medical needs in central nervous system, or CNS, disorders. The firms product include Nuplazid, which is used for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis. The company was founded by Mark R. Brann on July 16, 1993 and is headquartered in San Diego, CA.
---
Top 5 ETFs holding ACAD
Vanguard Total Stock Market ETF
$86.61M
Vanguard Health Care ETF
$8.19M
Vanguard U.S. Momentum Factor ETF
$195.23K
Schwab 1000 Index ETF
$194.43K
Vanguard Russell 3000 ETF
$177.58K
Up to five ETFs with an Outperform Smart Score that hold ACAD. The ETFs are listed according to market value of ACAD within the ETF
---